Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy

American Journal of Ophthalmology

Volumn 127, Issue 2, 1999, Pages 230-233

  Lauer, Andreas Katsuya ^a   Wobig, John L ^a   Shults, William T ^a   Neuwelt, Edward A ^b   Wilson, Matthew W ^c  

^a CASEY EYE INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CORTICOSTEROID; ETOPOFOS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EYE MOVEMENT; EYE TOXICITY; GLIOBLASTOMA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VISUAL ACUITY;

EID: 0033005591     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00346-8     Document Type: Article

References (5)

1. Moster M.L. Complications of cancer chemotherapy. Miller N.R., Newman N.J. Walsh and Hoyt's clinical neuro-ophthalmology, 5th ed. Volume 2. Chapter 48. 1998;2553-2644 Williams & Wilkins, Baltimore.
2. Margo C.E., Murtagh F.R. Ocular and orbital toxicity after intracarotid cisplatin therapy. Am J Ophthalmol. 116:1993;508-509.
3. Wu H.M., Lee A.G., Lehane D.E., et al. Ocular and orbital complications of intra-arterial cisplatin. J Neuroophthalmol. 17:1997;195-198.
4. Millay R.H., Klein M.L., Shults W.T., et al. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol. 102:1986;626-632.
5. Schacter L. Etoposide phosphate what, why, where and how? Semin Oncol. 23:(6 suppl 13):1996;1-7.